Skip to main content

Regulation of the Discovery, Development and Supply of New Drugs: Lessons for Medicine

  • Chapter
Regulation and Restraint in Contemporary Medicine in the UK and USA
  • 81 Accesses

Abstract

In view of the diverse interests represented in the subject of this meeting, the opening speaker should, I suppose, deal with aspects of regulation that affect all branches of medicine in its broadest sense. So, I shall use my own special field of interest (the process of drug development and its regulation) as a model for considering regulatory influences on medicine as a whole. There are some special features of the drug development process that will help to illuminate regulatory influences on all fields of medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Editor information

Hugh L’etang

Copyright information

© 1983 The Royal Society of Medicine

About this chapter

Cite this chapter

Wardell, W.M. (1983). Regulation of the Discovery, Development and Supply of New Drugs: Lessons for Medicine. In: L’etang, H. (eds) Regulation and Restraint in Contemporary Medicine in the UK and USA. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-06501-1_1

Download citation

Publish with us

Policies and ethics